cyclotide-based antibody therapeutic (Minotaur/Cyclogenix)

N/A

Report date: 2025/06/11 10:50:18

Base Information

Drug Namecyclotide-based antibody therapeutic (Minotaur/Cyclogenix)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > AntibodyBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsImmune System DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMinotaur Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCyclogenix LtdMinotaur Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsImmune System DiseasesNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A